The present invention is directed to nucleic acid molecules encoding
attenuated, non-functional virion infectivity factor (vif) proteins. The
nucleic acid molecules of the invention are inserted into recombinant
expression vectors and administered to mammals in order to induce a
cellular and humoral immune response to the encoded protein product.